SlimEasy Herbs Capsules Recalled for Undeclared Sibutramine
MyNicNaxs, Inc. is recalling SlimEasy Herbs Capsules because they contain undeclared sibutramine and N-desmethylsibutramine and were marketed without an approved NDA/ANDA.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of 5 according to the rubric.
Plain-English summary
MyNicNaxs, Inc. is recalling SlimEasy Herbs Capsules, 400 mg, supplied in 30-count boxes. The product was distributed nationwide by MyNicKnaxs, LLC, located in Deltona, Florida. The recall covers all lots of the product.
The FDA determined that the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). Additionally, the product was found to contain undeclared active pharmaceutical ingredients: sibutramine and N-desmethylsibutramine.
Consumers who have purchased this product should stop using it and contact the recalling firm for further instructions.
The recalled product
- Product
- SlimEasy Herbs Capsule, 400 mg, supplied in 30 count boxes, distributed by MyNicKnaxs, LLC, Deltona, FL
- Manufacturer
- MyNicNaxs, Inc.
- Category
- Drug — Dietary Supplement
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- ALL LOTS
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 10 recalled by MyNicNaxs, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · MyNicNaxs, Inc.
See all →- CriticalFDA Recalls Super Fat Burning Bomb Capsules for Undeclared Ingredients
FDA (Drugs) · 2014-06-18
- CriticalFruta BIO Capsules Recalled for Undeclared Active Pharmaceutical Ingredients
FDA (Drugs) · 2014-06-18
- CriticalSlim Xtreme Weight Loss Capsules Recalled for Undeclared Sibutramine Ingredients
FDA (Drugs) · 2014-06-18
- CriticalMeizitang Botanical Slimming Capsules Recalled for Undeclared Sibutramine Ingredients
FDA (Drugs) · 2014-06-18
- CriticalMeizi Evolution Soft Gel Capsules Recalled for Undeclared Active Ingredients
FDA (Drugs) · 2014-06-18
Same hazard · undeclared ingredient
See all →- ModerateWise Onion Rings recalled for undeclared food color additives
FDA (Food) · 2026-07-15
- ModerateDietary supplement Ocular Plus recalled for undeclared Yellow #5
FDA (Food) · 2026-07-08
- ModerateDietary Supplement Vista MAX Recalled for Undeclared Yellow #5 Allergen
FDA (Food) · 2026-07-08
- ModerateEl David Gelee Bonbons Recalled for Undeclared Color Additives
FDA (Food) · 2026-07-01
- HighAdndale magnesium glycinate gummies contain undeclared melatonin in three lots
FDA (Food) · 2026-06-24
Similar recalls
- CriticalSuper Herbs 350 mg capsules recalled for undeclared active ingredients
FDA (Drugs) · 2016-06-01
- CriticalFit Firm and Fabulous Recalls Ultimate Herbal Slimcap Capsules
FDA (Drugs) · 2016-02-24
- CriticalBotanicalNow BodySlim Herbal Capsules Recalled for Undeclared Sibutramine
FDA (Drugs) · 2018-01-31
- CriticalSlim Expert Softgels Recalled for Undeclared Sibutramine
FDA (Drugs) · 2014-04-23
- SevereSLIMFIT X capsules recalled for undeclared sibutramine and desmethylsibutramine
FDA (Drugs) · 2017-02-22
- CriticalFDA Recalls SlimeX-15 Capsules Containing Undeclared Sibutramine
FDA (Drugs) · 2016-07-13